EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Understanding Associations Between Patient‐Level Factors and Participation in a Breast Cancer Clinical Trial

Nicole E Caston, Luqin Deng, Courtney P Williams iD, Emily B Levitan, Andres Azuero, Russell Griffin, Karen L Smith, Antonio C Wolff, Michelle E Melisko, Eileen H Shinn, Kathleen Gallagher iD, Rebekah Angove und 2 weitere

Cancer Medicine · 2025

DOI: 10.1002/cam4.71010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2025. Verfasst von Nicole E Caston und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham (UAB), Birmingham, Alabama, USA. Hauptthemen laut MEDLINE: Breast Neoplasms, Clinical Trials as Topic, Patient Participation, Health Knowledge, Attitudes, Practice. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Breast Cancer Research Foundation of Alabama.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Although breast cancer (BC) clinical trials offer novel treatments, participating patients often do not represent populations seen in clinics. This study assessed how patient sociodemographics, attitudes, and knowledge about clinical trials may be associated with participation.

Methods

This cross sectional analysis used survey data collected August–September 2021 by Translational Breast Cancer Research Consortium (TBCRC) and December 2022 by Patient Advocate Foundation (PAF) among women with a BC diagnosis. Respondents reported BC clinical trial participation, Attitudes Toward Cancer Trials Scale, clinical trial knowledge, diagnosis age, race, education level, household income, employment status, and BC stage. Descriptive and bivariate analyses were conducted using Cramer's V or Cohen's d as effect sizes. Standardized total effects ( b Tot ) were estimated using a prespecified Structural Equation Model with 0.1, 0.3, and 0.5 indicating weak, medium, and large magnitude, respectively.

Results

Of 612 respondents, 26% were Black, Indigenous, or a Person of Color, 44% < Bachelor's degree, and 48% had incomes < $50,000. Respondents who reported trial participation (18%) more often had positive attitudes toward trials (mean 94 of 126, SD 19.3 vs. 86, SD 15.5; d = 0.48) compared to those not reporting participation. Positive attitude was associated with trial participation for both survey cohorts (TBCRC: b Tot = 0.22, p = 0.0002; PAF: b Tot = 0.13, p = 0.01). Furthermore, clinical trial knowledge was associated with attitudes (TBCRC: b Tot = 0.27, p = < 0.0001; PAF: b Tot = 0.15, p = 0.003).

Discussion

Although we found that positive attitudes and high knowledge were associated with clinical trial participation, it is unknown if the trial itself directly affected this. However, trial enrollment may be increased and diversified via future interventions focused on promotion of positive attitudes toward clinical trials, potentially through increased trial education and knowledge.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsClinical Trials as TopicPatient ParticipationHealth Knowledge, Attitudes, PracticeHumansFemaleMiddle AgedCross-Sectional StudiesAdultAgedSurveys and QuestionnairesSocioeconomic Factors

Stichwörter der Autor:innen

attitudes toward trialsbreast cancercancer clinical trialsclinical trial knowledgevulnerable populations

Autor:innen und Institutionen

  • Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham (UAB), Birmingham, Alabama, USA.
  • Department of Epidemiology, UAB, Birmingham, Alabama, USA.
  • Division of Preventive Medicine, UAB, Birmingham, Alabama, USA.
  • School of Nursing, UAB, Birmingham, Alabama, USA.
  • Merck, Rahway, New Jersey, USA.
  • Johns Hopkins University Sidney Kimmel Cancer Center, Baltimore, Maryland, USA.

ORCID-Profile: Courtney P Williams, Kathleen Gallagher, Gabrielle B Rocque

Förderung

  • Breast Cancer Research Foundation of Alabama

Zitieren

APA

Caston, N. E., Deng, L., Williams, C. P., Levitan, E. B., Azuero, A., Griffin, R., Smith, K. L., Wolff, A. C., Melisko, M. E., Shinn, E. H., Gallagher, K., Angove, R., Wheeler, S. B., & Rocque, G. B. (2025). Understanding Associations Between Patient‐Level Factors and Participation in a Breast Cancer Clinical Trial. Cancer Medicine. https://doi.org/10.1002/cam4.71010

Vancouver

Caston NE, Deng L, Williams CP, Levitan EB, Azuero A, Griffin R, et al. Understanding Associations Between Patient‐Level Factors and Participation in a Breast Cancer Clinical Trial. Cancer Medicine. 2025. doi:10.1002/cam4.71010

BibTeX
@article{Caston2025,
  author = {Caston, Nicole E and Deng, Luqin and Williams, Courtney P and Levitan, Emily B and Azuero, Andres and Griffin, Russell and Smith, Karen L and Wolff, Antonio C and Melisko, Michelle E and Shinn, Eileen H and Gallagher, Kathleen and Angove, Rebekah and Wheeler, Stephanie B and Rocque, Gabrielle B},
  title = {Understanding Associations Between Patient‐Level Factors and Participation in a Breast Cancer Clinical Trial},
  journal = {Cancer Medicine},
  year = {2025},
  doi = {10.1002/cam4.71010}
}
Kostenlos starten →